ELOX (Eloxx Pharmaceuticals) PS Ratio: (As of Jul. 04, 2026)


ELOX Eloxx Pharmaceuticals Inc ELOX
17 GF Score
Price $12.57
! 1 Warning Sign
View Full Analysis

What is Eloxx Pharmaceuticals PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Eloxx Pharmaceuticals's share price is $12.565. Eloxx Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00. Hence, Eloxx Pharmaceuticals's PS Ratio for today is .

The historical rank and industry rank for Eloxx Pharmaceuticals's PS Ratio or its related term are showing as below:

During the past 13 years, Eloxx Pharmaceuticals's highest PS Ratio was 273.03. The lowest was 0.05. And the median was 34.61.

ELOX's PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 9.64
* Ranked among companies with meaningful PS Ratio only.

Eloxx Pharmaceuticals's Revenue per Sharefor the six months ended in Dec. 2025 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00.

During the past 12 months, the average Revenue per Share Growth Rate of Eloxx Pharmaceuticals was -100.00% per year.

Back to Basics: PS Ratio


Eloxx Pharmaceuticals  (NAS:ELOX) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Eloxx Pharmaceuticals PS Ratio Related Terms


Eloxx Pharmaceuticals PS Ratio Historical Data

* Premium members only.

The historical data trend for Eloxx Pharmaceuticals's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eloxx Pharmaceuticals PS Ratio Chart

Eloxx Pharmaceuticals Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Eloxx Pharmaceuticals Semi-Annual Data
Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ELOX vs ESLA, RNXT, ABVC: PS Ratio Comparison

For the Biotechnology subindustry, Eloxx Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eloxx Pharmaceuticals PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eloxx Pharmaceuticals's PS Ratio distribution charts can be found below:

* The bar in red indicates where Eloxx Pharmaceuticals's PS Ratio falls into.


ELOX
17GF Score
Eloxx Pharmaceuticals Inc ELOX
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eloxx Pharmaceuticals PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Eloxx Pharmaceuticals's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=12.565/0
=

Eloxx Pharmaceuticals's Share Price of today is $12.565.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Eloxx Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Eloxx Pharmaceuticals Business Description

Address 10 Court Street, P.O. Box 274, Arlington, MA, USA, 02476
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
17GF Score

Get the complete analysis for ELOX

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.57
Price